Follow Us

10 Street Name, City Name
Country, Zip Code

555-555-5555
myemail@mailservice.com

Book an Audit
Logo

Resources

Additional funding sources and other opportunities for your business

Inquire Now

Find out if your business is eligible for CSC funding

At Commonwealth Seed Capital, our goal is to help move Kentucky’s innovative landscape forward. We do this by funding Kentucky businesses that have promising potential and meet our requirements. If your business meets the minimum requirements below, you might be eligible for CSC funding. If your business isn’t the right fit for our investment, we still want to see you succeed. Use the resources provided by the Kentucky Cabinet for Economic Development to take the next steps for your business.

✓ Headquartered in Kentucky

✓ At least 50% of payroll distributed in Kentucky

✓ At least 50% of business assets in Kentucky

Wondering about other funding opportunities in Kentucky?

Check out other funds in the state and find the best fit for your business.

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

  • Slide title

    Write your caption here
    Button

Innovation in Kentucky

Take a look at innovative Kentucky businesses below and see how they are pushing their industry forward

Inquire Now

AVAIL Now Supports Revit 2025, Announces New Features in Releases of Desktop Application and Revit Plugins

By Commonwealth Seed Capital Intern • May 15, 2024
Lexington, Ky. (May 15, 2024) - Software company AVAIL – which creates content management system (CMS) solutions for the global architecture, engineering, and construction (AEC) industry – has released AVAIL Desktop 4.6 along with Revit plugins AVAIL for Revit 5.2 and Harvest for Revit 2.4.

Switcher Brand Refresh: Stepping Outside the Studio

By Commonwealth Seed Capital Intern • May 6, 2024
Louisville, Ky. (May 6, 2024) – After ten years, Switcher is stepping outside the Studio! Announcing our 2024 brand refresh, some big product updates, and the future of Switcher — but first, how’d we get here?

Space Tango Returns NG-20 and SpX-30 Science to Customers

By Commonwealth Seed Capital Intern • April 30, 2024
Lexington, Ky. (April 30, 2024) – Space Tango, a leader in microgravity data analytics, biotechnology, and manufacturing; returned science samples to CubeLab customers today following the successful splashdown of SpaceX’s 30th Commercial Resupply Services (“CRS-30”) mission off the coast of Florida on April 30th.

Liberate Medical Announces PREVENT Study with $6.5M Grant Funding from the US DoD – Enrolls First Patients Globally

By Commonwealth Seed Capital Intern • April 9, 2024
Crestwood, Ky. (April 9, 2024) – Liberate Medical is proud to announce the successful commencement of patient enrollment in the PREVENT trial, a pivotal clinical trial examining the VentFree Respiratory Muscle Stimulator.

First Stop Health Announces New Chief Medical Officer

By Commonwealth Seed Capital Intern • February 21, 2024
Chicago, Il. (February 21, 2024) – First Stop Health (FSH), a leading virtual care company for primary, urgent and mental health care needs, today announced Cole Barfield MD, MBA as the new Chief Medical Officer.

Kindeva Drug Delivery Acquires Summit Biosciences, a Specialized Nasal Drug Development and Manufacturing Organization

By Commonwealth Seed Capital Intern • January 18, 2024
Woodbury, Minn., St. Louis, Mo., Lexington, Ky. (January 18, 2024) – Kindeva Drug Delivery (“Kindeva”), a global leader in drug-device combination products, announced today that it has acquired Summit Biosciences Inc. (“Summit”), an intranasal drug-delivery contract development and manufacturing organization (CDMO), from its founding family shareholders.

What are you waiting for? Find out if your business is eligible for CSC funding

Inquire Now
Share by: